| Literature DB >> 34350219 |
Zhen Zhang1, Qiaozhi Ma2, Yiyuan Gao1, Lizhen Cao3, Chengcheng Zhu4, Zhiwei Zhao5, Jun Zhao5, Linan Zeng5, Mingwu Lou1, Gerald M Pohost5,6, Kuncheng Li3,5.
Abstract
Background: Quantification of cardiac structure and function is essential for diagnostic interpretation and clinical decision making. We sought to establish cardiovascular magnetic resonance (CMR) reference values of left and right ventricular (LV and RV) morphology and function based on a large sample of healthy Chinese adults.Entities:
Keywords: Chinese adults; cardiovascular magnetic resonance; left ventricle; reference value; right ventricle
Year: 2021 PMID: 34350219 PMCID: PMC8326328 DOI: 10.3389/fcvm.2021.697481
Source DB: PubMed Journal: Front Cardiovasc Med ISSN: 2297-055X
Figure 1Example of left ventricular (LV) and right ventricular (RV) functional analysis on the short-axis cine images of end-diastole (A) and end-systole (B).
Demographic characteristics of the studied population.
| Age (years) | 43.1 ± 11.6 | 43.0 ± 11.1 | 43.4 ± 12.2 | 0.660 |
| Height (cm) | 167.0 ± 8.1 | 171.6 ± 6.1 | 160.4 ± 5.8 | <0.001 |
| Body weight (kg) | 63.8 ± 10.8 | 69.5 ± 9.1 | 55.6 ± 7.1 | <0.001 |
| BMI (kg/m2) | 22.8 ± 2.8 | 23.6 ± 2.5 | 21.6 ± 2.6 | <0.001 |
| BSA (m2) | 1.72 ± 0.18 | 1.82 ± 0.14 | 1.57 ± 0.11 | <0.001 |
| HR (bpm) | 66.9 ± 9.6 | 66.3 ± 9.8 | 67.8 ± 9.2 | 0.077 |
| SBP (mm Hg) | 114.3 ± 12.9 | 117.3 ± 10.8 | 110.0 ± 14.4 | <0.001 |
| DBP (mm Hg) | 70.4 ± 9.3 | 72.7 ± 8.7 | 67.2 ± 9.2 | <0.001 |
| FBG (mmol/L) | 5.18 ± 0.44 | 5.24 ± 0.44 | 5.09 ± 0.43 | <0.001 |
Data are presented as means ± standard deviation. p-Value is for t-test between genders.
BMI, body mass index; BSA, body surface area; HR, heart rate; SBP, systolic blood pressure; DBP, diastolic blood pressure; FBG, fasting blood glucose.
Absolute and indexed left ventricular (LV) and right ventricular (RV) parameters for men and women.
| LVEDV (ml) | 104.6 ± 20.0 | 111.6 ± 19.8 | 94.6 ± 15.6 | <0.001 |
| LVESV (ml) | 33.1 ± 9.9 | 36.5 ± 9.8 | 28.2 ± 7.9 | <0.001 |
| LVSV (ml) | 71.5 ± 13.2 | 75.2 ± 13.3 | 66.3 ± 11.0 | <0.001 |
| LVEF (%) | 68.7 ± 5.7 | 67.5 ± 5.4 | 70.4 ± 5.7 | <0.001 |
| LVCO (L/min) | 4.8 ± 1.0 | 4.9 ± 1.0 | 4.5 ± 0.9 | <0.001 |
| LVM (g) | 106.6 ± 24.9 | 121.1 ± 19.9 | 86.1 ± 14.5 | <0.001 |
| Global end-diastolic LVWT (mm) | 7.5 ± 1.3 | 8.1 ± 1.1 | 6.7 ± 1.0 | <0.001 |
| LVEDV/BSA (ml/m2) | 60.9 ± 9.7 | 61.4 ± 10.1 | 60.2 ± 9.2 | 0.152 |
| LVESV/BSA (ml/m2) | 19.2 ± 5.2 | 20.1 ± 5.2 | 18.0 ± 5.0 | <0.001 |
| LVSV/BSA (ml/m2) | 41.7 ± 6.6 | 41.3 ± 6.8 | 42.2 ± 6.3 | 0.114 |
| LVM/BSA (g/m2) | 61.6 ± 10.3 | 66.5 ± 9.2 | 54.7 ± 7.4 | <0.001 |
| Global end-diastolic LVWT/BSA (mm/m2) | 4.4 ± 0.6 | 4.5 ± 0.6 | 4.2 ± 0.6 | <0.001 |
| RVEDV (ml) | 117.2 ± 24.8 | 128.0 ± 23.6 | 101.7 ± 17.0 | <0.001 |
| RVESV (ml) | 46.6 ± 14.5 | 53.5 ± 13.7 | 36.8 ± 8.9 | <0.001 |
| RVSV (ml) | 70.6 ± 13.2 | 74.6 ± 13.2 | 64.9 ± 11.1 | <0.001 |
| RVEF (%) | 60.8 ± 5.9 | 58.5 ± 5.2 | 64.0 ± 5.3 | <0.001 |
| RVCO (L/min) | 4.7 ± 1.0 | 4.9 ± 1.0 | 4.4 ± 0.9 | <0.001 |
| RVEDV/BSA (ml/m2) | 68.0 ± 11.5 | 70.4 ± 11.6 | 64.5 ± 10.6 | <0.001 |
| RVESV/BSA (ml/m2) | 26.9 ± 6.9 | 29.4 ± 6.8 | 23.4 ± 5.5 | <0.001 |
| RVSV/BSA (ml/m2) | 41.1 ± 6.6 | 41.0 ± 6.9 | 41.3 ± 6.3 | 0.574 |
p-value is for t-test between genders.
BSA, body surface area; EDV, end-diastolic volume; ESV, end-systolic volume; SV, stroke volume; EF, ejection fraction; CO, cardiac output; LVM, left ventricular mass; LVWT, left ventricular wall thickness.
Figure 2Segmental end-diastolic left ventricular wall thickness (LVWT) [according to the American Heart Association (AHA) model] for men (A) and women (B). The end-diastolic LVWT is presented as “mean ± standard deviation.”
Absolute and indexed LV parameters by age decile for men (n = 323).
| LVEDV (ml) | 122.4 ± 20.8 | 113.3 ± 18.1 | 111.2 ± 20.2 | 104.9 ± 17.6 | 99.7 ± 17.9 |
| LVESV (ml) | 43.2 ± 10.7 | 37.8 ± 8.7 | 36.0 ± 9.1 | 33.8 ± 9.5 | 28.6 ± 7.7 |
| LVSV (ml) | 79.2 ± 13.4 | 75.4 ± 12.8 | 76.2 ± 14.5 | 71.0 ± 10.4 | 71.1 ± 13.5 |
| LVEF (%) | 64.9 ± 5.0 | 66.7 ± 4.9 | 68.0 ± 5.3 | 68.2 ± 5.3 | 71.4 ± 5.8 |
| LVCO (L/min) | 5.5 ± 1.3 | 4.9 ± 1.0 | 4.9 ± 0.9 | 4.7 ± 0.9 | 4.7 ± 1.0 |
| LVM (g) | 122.2 ± 21.6 | 118.2 ± 19.4 | 122.9 ± 21.0 | 122.6 ± 18.0 | 121.9 ± 19.3 |
| LVEDV/BSA (ml/m2) | 67.5 ± 9.3 | 62.3 ± 9.2 | 61.4 ± 10.2 | 57.3 ± 9.4 | 56.5 ± 9.9 |
| LVESV/BSA (ml/m2) | 23.8 ± 5.2 | 20.8 ± 4.6 | 19.7 ± 4.8 | 18.5 ± 5.0 | 16.3 ± 4.7 |
| LVSV/BSA (ml/m2) | 43.7 ± 6.3 | 41.5 ± 6.6 | 41.7 ± 7.4 | 38.9 ± 5.7 | 40.2 ± 7.0 |
| LVM/BSA (g/m2) | 67.1 ± 8.4 | 64.9 ± 9.2 | 67.2 ± 9.9 | 66.9 ± 8.2 | 68.8 ± 8.9 |
Abbreviations as in .
Absolute and indexed RV parameters by age decile for women (n = 227).
| RVEDV (ml) | 107.0 ± 15.3 | 105.0 ± 13.4 | 102.2 ± 16.1 | 95.2 ± 22.1 | 94.6 ± 16.2 |
| RVESV (ml) | 41.8 ± 8.7 | 38.7 ± 8.0 | 37.1 ± 8.1 | 32.9 ± 8.7 | 30.3 ± 7.2 |
| RVSV (ml) | 65.3 ± 9.9 | 66.3 ± 8.6 | 65.2 ± 11.5 | 62.3 ± 14.7 | 64.3 ± 10.7 |
| RVEF (%) | 61.1 ± 5.0 | 63.3 ± 4.8 | 63.8 ± 5.4 | 65.5 ± 4.2 | 68.2 ± 4.6 |
| RVCO (L/min) | 4.5 ± 0.9 | 4.5 ± 0.7 | 4.3 ± 1.0 | 4.2 ± 1.0 | 4.4 ± 0.8 |
| RVEDV/BSA (ml/m2) | 69.5 ± 7.4 | 66.6 ± 11.2 | 64.3 ± 9.5 | 59.8 ± 11.5 | 59.6 ± 9.8 |
| RVESV/BSA (ml/m2) | 27.1 ± 5.0 | 24.9 ± 4.9 | 23.3 ± 5.0 | 20.6 ± 4.7 | 19.1 ± 4.5 |
| RVSV/BSA (ml/m2) | 42.4 ± 5.0 | 42.7 ± 5.0 | 41.0 ± 6.7 | 39.2 ± 7.8 | 40.6 ± 6.6 |
Abbreviations as in .
Figure 3Correlation between biventricular end-diastolic volume (EDV), end stroke volume (ESV), ejection fraction (EF), and age in men and women. Linear regressions with 95% confidence intervals for left ventricular EDV (LVEDV) (A), left ventricular ESV (LVESV) (B), left ventricular EF (LVEF) (C), right ventricular EDV (RVEDV) (D), right ventricular ESV (RVESV) (E), and right ventricular EF (RVEF) (F).
Figure 4Correlation between global end-diastolic LVWT, left ventricular mass (LVM), LVM/LVEDV, and age for men and women. Linear regressions with 95% confidence intervals for global end-diastolic LVWT (A), LVM (B), and LVM/LVEDV (C).
Figure 5Bland–Altman plots for inter-observer and intra-observer reproducibility of LVEDV, LVESV, LVEF, and LVM.
Figure 6Bland–Altman plots for inter-observer and intra-observer reproducibility of RVEDV, RVESV, and RVEF.
Absolute and indexed LV parameters by age decile for women (n = 227).
| LVEDV (ml) | 99.9± 14.6 | 97.4 ± 12.5 | 95.0 ± 14.2 | 89.3 ± 19.8 | 86.9 ± 15.4 |
| LVESV (ml) | 33.5 ± 7.3 | 29.5 ± 6.2 | 28.1 ± 7.9 | 25.3 ± 7.9 | 22.1 ± 6.1 |
| LVSV (ml) | 66.5 ± 10.7 | 67.8 ± 9.3 | 66.9 ± 10.4 | 64.0 ± 14.4 | 64.8 ± 11.2 |
| LVEF (%) | 66.5 ± 4.9 | 69.8 ± 4.9 | 70.6 ± 6.1 | 71.8 ± 5.3 | 74.8 ± 4.5 |
| LVCO (L/min) | 4.6 ± 0.9 | 4.6 ± 0.7 | 4.4 ± 0.9 | 4.3 ± 1.0 | 4.4 ± 0.8 |
| LVM (g) | 79.7 ± 9.1 | 82.1 ± 13.5 | 86.6 ± 13.6 | 91.9 ± 16.5 | 94.7 ± 15.3 |
| LVEDV/BSA (ml/m2) | 64.9 ± 7.0 | 62.7 ± 7.7 | 59.8 ± 8.6 | 55.8 ± 10.2 | 54.9 ± 9.6 |
| LVESV/BSA (ml/m2) | 21.8 ± 4.2 | 19.0 ± 4.1 | 17.8 ± 5.1 | 15.9 ± 4.5 | 14.0 ± 3.8 |
| LVSV/BSA (ml/m2) | 43.2 ± 5.3 | 43.7 ± 5.5 | 42.1 ± 6.0 | 40.2 ± 7.5 | 40.9 ± 7.0 |
| LVM/BSA (g/m2) | 52.0 ± 5.9 | 52.6 ± 7.0 | 54.4 ± 7.0 | 57.8 ± 7.9 | 59.4 ± 6.8 |
Abbreviations as in .
Absolute and indexed end-diastolic left ventricular wall thickness (LVWT) by age decile for men (n = 323).
| Global (mm) | 7.7 ± 0.9 | 7.9 ± 1.0 | 8.2 ± 1.1 | 8.5 ± 1.0 | 8.7 ± 1.1 |
| Basal (mm) | 8.5 ± 0.8 | 8.7 ± 1.0 | 9.1 ± 1.2 | 9.3 ± 1.0 | 9.6 ± 1.3 |
| Middle-cavity (mm) | 7.6 ± 0.9 | 7.8 ± 1.0 | 8.0 ± 1.2 | 8.4 ± 1.0 | 8.5 ± 1.1 |
| Apical (mm) | 6.8 ± 1.1 | 7.0 ± 1.2 | 7.2 ± 1.3 | 7.7 ± 1.1 | 7.6 ± 0.9 |
| Global (mm/m2) | 4.3 ± 0.5 | 4.4 ± 0.5 | 4.5 ± 0.6 | 4.7 ± 0.6 | 4.9 ± 0.6 |
| Basal (mm/m2) | 4.7 ± 0.4 | 4.8 ± 0.5 | 5.0 ± 0.6 | 5.1 ± 0.5 | 5.5 ± 0.7 |
| Middle-cavity (mm/m2) | 4.2 ± 0.5 | 4.3 ± 0.5 | 4.4 ± 0.6 | 4.6 ± 0.6 | 4.8 ± 0.6 |
| Apical (mm/m2) | 3.7 ± 0.6 | 3.9 ± 0.7 | 3.9 ± 0.7 | 4.2 ± 0.7 | 4.3 ± 0.5 |
BSA, body surface area.
Absolute and indexed end-diastolic LVWT by age decile for women (n = 227).
| Global (mm) | 6.0 ± 0.6 | 6.3 ± 0.8 | 6.7 ± 0.8 | 7.2 ± 0.8 | 7.7 ± 1.0 |
| Basal (mm) | 6.5 ± 0.6 | 6.8 ± 0.9 | 7.3 ± 0.9 | 7.8 ± 0.9 | 8.4 ± 1.2 |
| Middle-cavity (mm) | 6.0 ± 0.6 | 6.1 ± 0.9 | 6.6 ± 0.8 | 7.1 ± 0.9 | 7.5 ± 0.9 |
| Apical (mm) | 5.2 ± 0.8 | 5.6 ± 1.4 | 5.8 ± 0.9 | 6.4 ± 0.9 | 6.8 ± 1.0 |
| Global (mm/m2) | 3.9 ± 0.5 | 4.0 ± 0.5 | 4.2 ± 0.5 | 4.6 ± 0.6 | 4.8 ± 0.5 |
| Basal (mm/m2) | 4.3 ± 0.5 | 4.4 ± 0.5 | 4.6 ± 0.5 | 5.0 ± 0.6 | 5.3 ± 0.6 |
| Middle-cavity (mm/m2) | 3.9 ± 0.5 | 3.9 ± 0.5 | 4.2 ± 0.5 | 4.5 ± 0.6 | 4.7 ± 0.5 |
| Apical (mm/m2) | 3.4 ± 0.6 | 3.6 ± 1.0 | 3.6 ± 0.5 | 4.0 ± 0.6 | 4.3 ± 0.5 |
BSA, body surface area.
Absolute and indexed RV parameters by age decile for men (n = 323).
| RVEDV (ml) | 140.7 ± 26.5 | 129.5 ± 20.8 | 129.2 ± 25.6 | 119.3 ± 18.5 | 116.0 ± 19.8 |
| RVESV (ml) | 62.1 ± 16.1 | 54.7 ± 12.2 | 54.2 ± 13.7 | 48.0 ± 11.4 | 44.2 ± 9.6 |
| RVSV (ml) | 79.4 ± 13.5 | 74.8 ± 12.5 | 74.8 ± 14.7 | 71.3 ± 9.7 | 71.8 ± 13.8 |
| RVEF (%) | 56.5 ± 5.1 | 57.9 ± 5.2 | 58.2 ± 4.7 | 60.1 ± 4.9 | 61.9 ± 5.7 |
| RVCO (L/min) | 5.5 ± 1.3 | 4.9 ± 0.9 | 4.8 ± 0.9 | 4.7 ± 0.9 | 4.8 ± 1.1 |
| RVEDV/BSA (ml/m2) | 78.0 ± 11.6 | 71.1 ± 10.3 | 70.7 ± 12.7 | 65.1 ± 9.0 | 65.6 ± 9.9 |
| RVESV/BSA (ml/m2) | 34.1 ± 7.5 | 30.0 ± 6.1 | 29.6 ± 6.9 | 26.1 ± 5.6 | 25.0 ± 5.1 |
| RVSV/BSA (ml/m2) | 43.9 ± 6.3 | 41.1 ± 6.6 | 41.0 ± 7.4 | 38.9 ± 5.0 | 39.8 ± 8.3 |
Abbreviations as in .